Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
Are weight-loss drugs like gym memberships? The answer is worth billions
An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.
Eli Lilly and Company (NYSE:LLY) Lowered to Hold Rating by StockNews.com
Eli Lilly and Company (NYSE:LLY – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold ...
Is Trump's 'buyout offer' a good deal for -2-
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. The industry has struggled to ...
Thermo Fisher Scientific Up Over 6%, on Pace for Largest Percent Increase Since November 2022 — Data Talk
Up 16.34% month-to-date; on pace for best month since April 2020, when it rose 18.01% --Up 16.34% year-to-date --Down 9.29% from its all-time closing high of $667.24 on Dec. 31, 2021 --Up 9.6% from 52 ...